Atlas Trials

Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC

Clinical trial NCT04421469 · UNKNOWN

Trial details

NCT number
NCT04421469
Sponsor
Fujian Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Nasopharyngeal Carcinoma
Start date
2020-06-15
Primary completion
2023-04-15
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.